Ortin Global logo

Ortin Global

ORTINGLOBE NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹13.80 Cr
Volatility
Moderate
P/E Ratio
-14.5
EBITDA
₹-1.04 Cr
Return on Equity
-42.8%
Debt to Equity
0.81
Book Value
₹1.53
52W High
₹21.3
52W Low
₹10.66

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Debtor days have improved from 260 to 178 days.

Weaknesses

9
  • Stock is trading at 11.2 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -45.0% over past five years.
  • Promoter holding is low: 1.23%
  • Company has a low return on equity of -72.7% over last 3 years.
  • Contingent liabilities of Rs.24.3 Cr.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 178 days.
  • Promoter holding has decreased over last 3 years: -6.13%

Growth Rate

Revenue Growth
-75% lower than 3Y
Net Income Growth
-10% higher than 3Y
Cash Flow Change
91.44% higher than 3Y
ROE
-84.97% higher than 3Y
ROCE
-73.7%
EBITDA Margin (Avg.)
—

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
1.57
0.27
0.14
0.3
0.21
0.05
0.03
0.09
0.08
0.01
0.01
0.3
0.01
Expenses
1.39
1.17
2.74
3.35
0.31
0.5
0.16
0.25
0.24
0.51
0.06
0.31
0.34
Operating Profit
0.18
-0.9
-2.6
-3.05
-0.1
-0.45
-0.13
-0.16
-0.16
-0.5
-0.05
-0.01
-0.33
OPM %
11.46%
-333.33%
-1857.14%
-1016.67%
-47.62%
-900%
-433.33%
-177.78%
-200%
-5000%
-500%
-3.33%
-3300%
Other Income
0
0
0
0
0
0
0.02
0
0
0
0
0
0
Interest
0.11
0.15
0.14
0.08
0
0.02
-0.01
0
0
0
0
0
0
Depreciation
0.06
0.06
0.06
0.05
0
0
0
0
0
0
0
0
0
PBT
0.01
-1.11
-2.8
-3.18
-0.1
-0.47
-0.1
-0.16
-0.16
-0.5
-0.05
-0.01
-0.33
Tax %
0%
1.8%
-0.71%
30.19%
0%
0%
10%
0%
6.25%
0%
0%
0%
0%
Net Profit
0.02
-1.12
-2.79
-4.14
-0.1
-0.47
-0.11
-0.16
-0.18
-0.5
-0.05
-0.01
-0.34
EPS in Rs
0.02
-1.38
-3.43
-5.09
-0.12
-0.58
-0.14
-0.2
-0.22
-0.61
-0.06
-0.01
-0.42
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
60.29
62.72
61.57
79.63
168
197
8.16
8.23
6
2.01
0.34
0.41
0.33
Expenses
53.8
56.83
56.12
74.22
161
192
6.92
7.85
5.47
6.4
1.23
1.13
1.22
Operating Profit
6.49
5.89
5.45
5.41
6.68
5.7
1.24
0.38
0.53
-4.39
-0.89
-0.72
-0.89
OPM %
10.76%
9.39%
8.85%
6.79%
3.99%
2.89%
15.2%
4.62%
8.83%
-218.41%
-261.76%
-175.61%
-269.7%
Other Income
0
0.57
0.32
0.45
0.13
0.18
0.05
0.19
0.01
-1.98
0.06
0
0
Interest
3.52
3.42
2.94
3.49
3.22
3.21
0.87
0.81
0.4
0.48
0
0
0
Depreciation
1.64
1.65
1.7
1.69
1.75
1.96
0.29
0.29
0.25
0.23
0.01
0
0
PBT
1.33
1.39
1.13
0.68
1.84
0.71
0.13
-0.53
-0.11
-7.08
-0.84
-0.72
-0.89
Tax %
32.33%
41.01%
55.75%
0%
30.43%
181.69%
-623.08%
-24.53%
-18.18%
13.56%
1.19%
2.78%
—
Net Profit
0.9
0.83
0.5
0.68
1.28
-0.56
0.95
-0.4
-0.09
-8.04
-0.85
-0.74
-0.9
EPS in Rs
0.53
0.49
0.3
0.4
0.76
-0.33
1.17
-0.49
-0.11
-9.89
-1.05
-0.91
-1.1
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
16.94
16.94
16.94
16.94
16.94
16.94
8.13
8.13
8.13
8.13
8.13
8.13
Reserves
5.5
6.33
6.46
7.14
8.15
6.88
3.22
2.83
2.73
-5.31
-6.15
-6.89
Borrowings
20.96
20.85
17.34
17.34
19.47
19.57
6.94
6.14
6.45
1.8
0.25
1.01
Other Liabilities
23.87
21.22
20.79
32.24
60.53
73.13
2.97
3.61
3.89
2.05
1.55
2.4
Total Liabilities
67.27
65.34
61.53
73.66
105
117
21.26
20.71
21.2
6.67
3.78
4.65
Fixed Assets
21.83
21.63
20.69
20.03
21.29
22.45
14.38
14.21
13.96
0.01
0
0.01
CWIP
0
0
0.35
0.4
0.53
0.43
0.43
0.43
0.43
0
0
0
Investments
0.03
0.03
0.07
0.08
0.08
0.07
0
0
0
0
0
0
Other Assets
45.41
43.68
40.42
53.15
83.19
93.57
6.45
6.07
6.81
6.66
3.78
4.64
Total Assets
67.27
65.34
61.53
73.66
105
117
21.26
20.71
21.2
6.67
3.78
4.65
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-1.38
0.52
1.94
1.56
6.52
3.3
18.03
2.15
-0.25
-4.79
-0.41
-0.56
Investing
0.22
-0.86
-1.26
-0.9
-3.27
-3.09
0.07
-0.13
0.01
12
0
0.04
Financing
1.73
0.27
-0.82
0.07
-2.89
-1.33
-9.86
-0.48
0.9
-3.49
0.33
0.75
Net Cash Flow
0.58
-0.07
-0.14
0.73
0.37
-1.12
8.25
1.55
0.66
3.72
-0.09
0.23
Free Cash Flow
-1.38
-0.92
0.83
0.77
3.38
0.28
18.03
2.02
-0.24
7.21
-0.41
-0.52
CFO/OP
-14
17
47
40
104
72
1,454
566
-47
80
46
78
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
104
53.13
90.35
100
82.43
68.71
175
144
208
321
279
178
Inventory Days
192
149
158
152
100
118
169
136
280
4.92
34.76
0
Days Payable
151
24.82
108
143
145
156
124
61.88
167
7.87
69.52
—
Cash Conversion Cycle
145
177
140
109
37.38
30.7
220
218
321
318
244
178
Working Capital Days
29
16.24
37.29
41.48
16.82
11.24
-87.22
-109
-43.19
358
1,524
730
ROCE %
12.07%
10.92%
9.57%
9.44%
11.77%
8.94%
3.24%
1.58%
1.8%
-40.58%
-25.11%
-32.14%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Ortin Global insights

63 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

Promot.1.23%Public90.87%FIIs1.80%Others6.10%As ofJun 2026

Documents

Frequently Asked Questions about Ortin Global

What does Ortin Global Ltd do?
Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations.[1]
Where is Ortin Global Ltd (ORTINGLOBE) listed?
Ortin Global Ltd trades as ORTINGLOBE on the NSE and under code 539287 on the BSE.
Which sector does Ortin Global Ltd belong to?
Ortin Global Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Ortin Global Ltd?
Ortin Global Ltd has a market capitalisation of ₹13.8 Cr, which places it in the Small Cap band.
What is the PE ratio of Ortin Global Ltd?
Ortin Global Ltd trades at a PE ratio of -14.50, against a book value of ₹1.53 per share.
What is the 52-week high and low of Ortin Global Ltd?
Over the last 52 weeks Ortin Global Ltd has traded between ₹10.66 and ₹21.3.
What is the Return on Equity (ROE) of Ortin Global Ltd?
Ortin Global Ltd reported a return on equity of -42.80%. Its debt-to-equity ratio is 0.81.

Company Information

Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations.[1]

Website ortinlabsindia.com
Listed 2021-03-30
Face Value ₹ 10
Issued Size 81,31,392

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ORTINGLOBE.md for Ortin Global Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List